Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» umbralisib
umbralisib
Watch out, Gilead: TG Therapeutics wins FDA nod for potentially safer Zydelig rivalrnings season continues to show COVID-19 uncertainty
Fierce Pharma
Mon, 02/8/21 - 10:38 pm
TG Therapeutics
FDA
Ukoniq
umbralisib
follicular lymphoma
marginal zone lymphoma
Gilead Sciences
3 FDA Dates Biotech Investors Should Circle in 2021
Motley Fool
Sat, 12/26/20 - 08:27 pm
FDA
biotech
Bluebird Bio
ide-cel
Multiple Myeloma
Biogen
aducanumab
Alzheimer's disease
targeted therapeutics
umbralisib
maringal zone lymphoma
FDA to decide on TG Therapeutics’ lymphoma drug early next year
Pharmaforum
Thu, 08/13/20 - 11:53 pm
TG Therapeutics
FDA
lymphoma
umbralisib
Bristol-Myers Squibb
Roche
TG aims for accelerated approval of lymphoma candidate
BioCentury
Fri, 03/1/19 - 09:37 am
TG Therapeutics
umbralisib
TGR-1202
lymphoma
3 Biotech Stocks With Major Catalysts Incoming
Motley Fool
Mon, 08/13/18 - 11:26 am
TG Therapeutics
Sangamo Therapeutics
Akcea Therapeutics
FDA
Waylivra
umbralisib
SB-913
ASCO 2018 Sends TG Therapeutics Stock Soaring 10% Today
Motley Fool
Mon, 06/4/18 - 09:55 pm
TG Therapeutics
umbralisib
chronic lymphocytic leukemia
ASCO 2018